代謝型グルタミン酸受容体2の世界市場レポート2020

• 英文タイトル：Global Metabotropic Glutamate Receptor 2 Sales Market Report 2020

• レポートコード：20QY06-07225
• 出版社/出版日：QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、132ページ
• 納品方法：Eメール（受注後2~3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社の当調査資料では、代謝型グルタミン酸受容体2のグローバル市場について種類別（LY-2607540、BMT-133218、DT-2442、JNJ-40411813、その他）、用途別（不安障害、うつ病、統合失調症、慢性疼痛、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・代謝型グルタミン酸受容体2市場の概要
・世界の主要地域別代謝型グルタミン酸受容体2市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の代謝型グルタミン酸受容体2市場規模2015-2026：種類別（LY-2607540、BMT-133218、DT-2442、JNJ-40411813、その他）
・世界の代謝型グルタミン酸受容体2市場規模2015-2026：用途別（不安障害、うつ病、統合失調症、慢性疼痛、その他）
・代謝型グルタミン酸受容体2の北米市場規模2015-2020
・代謝型グルタミン酸受容体2のヨーロッパ市場規模2015-2020
・代謝型グルタミン酸受容体2の中国市場規模2015-2020
・代謝型グルタミン酸受容体2の日本市場規模2015-2020
・代謝型グルタミン酸受容体2の東南アジア市場規模2015-2020
・代謝型グルタミン酸受容体2のインド市場規模2015-2020
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Addex Therapeutics Ltd、Bristol-Myers Squibb Company、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Johnson & Johnson、Merck & Co Inc）
・代謝型グルタミン酸受容体2の製造コスト分析
・販売チャネル、流通業者、顧客
・代謝型グルタミン酸受容体2の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Metabotropic Glutamate Receptor 2 Market
The global Metabotropic Glutamate Receptor 2 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Metabotropic Glutamate Receptor 2 Scope and Market Size
The global Metabotropic Glutamate Receptor 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Metabotropic Glutamate Receptor 2 market is segmented into
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others

Segment by Application, the Metabotropic Glutamate Receptor 2 market is segmented into
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
The Metabotropic Glutamate Receptor 2 market is analysed and market size information is provided by regions (countries). Segment by Application, the Metabotropic Glutamate Receptor 2 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Metabotropic Glutamate Receptor 2 Market Share Analysis
Metabotropic Glutamate Receptor 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Metabotropic Glutamate Receptor 2 business, the date to enter into the Metabotropic Glutamate Receptor 2 market, Metabotropic Glutamate Receptor 2 product introduction, recent developments, etc.
The major vendors covered:
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
…

レポート目次

Table of Contents

1 Metabotropic Glutamate Receptor 2 Market Overview
1.1 Metabotropic Glutamate Receptor 2 Product Scope
1.2 Metabotropic Glutamate Receptor 2 Segment by Type
1.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2020-2026)
1.2.2 LY-2607540
1.2.3 BMT-133218
1.2.4 DT-2442
1.2.5 JNJ-40411813
1.2.6 Others
1.3 Metabotropic Glutamate Receptor 2 Segment by Application
1.3.1 Global Metabotropic Glutamate Receptor 2 Sales Comparison by Application (2020-2026)
1.3.2 Anxiety Disorders
1.3.3 Depression
1.3.4 Schizophrenia
1.3.5 Chronic Pain
1.3.6 Others
1.4 Metabotropic Glutamate Receptor 2 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Metabotropic Glutamate Receptor 2 Sales Growth Rate (2015-2026)
1.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Growth Rate (2015-2026)
1.4.3 Global Metabotropic Glutamate Receptor 2 Price Trends (2015-2026)

2 Metabotropic Glutamate Receptor 2 Estimate and Forecast by Region
2.1 Global Metabotropic Glutamate Receptor 2 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Metabotropic Glutamate Receptor 2 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2015-2020)
2.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2015-2020)
2.3 Global Metabotropic Glutamate Receptor 2 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Metabotropic Glutamate Receptor 2 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
2.4.2 Europe Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
2.4.3 China Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
2.4.4 Japan Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
2.4.6 India Metabotropic Glutamate Receptor 2 Estimates and Projections (2015-2026)
3 Global Metabotropic Glutamate Receptor 2 Competition Landscape by Players
3.1 Global Top Metabotropic Glutamate Receptor 2 Players by Sales (2015-2020)
3.2 Global Top Metabotropic Glutamate Receptor 2 Players by Revenue (2015-2020)
3.3 Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2019)
3.4 Global Metabotropic Glutamate Receptor 2 Average Price by Company (2015-2020)
3.5 Manufacturers Metabotropic Glutamate Receptor 2 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Metabotropic Glutamate Receptor 2 Players (Opinion Leaders)
4 Global Metabotropic Glutamate Receptor 2 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 2 Historic Market Review by Type (2015-2020)
4.1.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2015-2020)
4.1.3 Global Metabotropic Glutamate Receptor 2 Price by Type (2014-2020)
4.2 Global Metabotropic Glutamate Receptor 2 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Type (2021-2026)
4.2.3 Global Metabotropic Glutamate Receptor 2 Price Forecast by Type (2021-2026)
5 Global Metabotropic Glutamate Receptor 2 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 2 Historic Market Review by Application (2015-2020)
5.1.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
5.1.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2015-2020)
5.1.3 Global Metabotropic Glutamate Receptor 2 Price by Application (2015-2020)
5.2 Global Metabotropic Glutamate Receptor 2 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Metabotropic Glutamate Receptor 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Metabotropic Glutamate Receptor 2 Price Forecast by Application (2021-2026)

3 North America Metabotropic Glutamate Receptor 2 Market Facts & Figures
3.2 North America Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
3.3 North America Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
3.4 North America Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

4 Europe Metabotropic Glutamate Receptor 2 Market Facts & Figures
4.2 Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
4.3 Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
4.4 Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

5 China Metabotropic Glutamate Receptor 2 Market Facts & Figures
5.2 China Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
5.3 China Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
5.4 China Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

6 Japan Metabotropic Glutamate Receptor 2 Market Facts & Figures
6.2 Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
6.3 Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
6.4 Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

7 Southeast Asia Metabotropic Glutamate Receptor 2 Market Facts & Figures
7.2 Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

8 India Metabotropic Glutamate Receptor 2 Market Facts & Figures
8.2 India Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
8.3 India Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
8.4 India Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Metabotropic Glutamate Receptor 2 Business
12.1 Addex Therapeutics Ltd
12.1.1 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Corporation Information
12.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Products Offered
12.1.5 Addex Therapeutics Ltd Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Corporation Information
12.2.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Products Offered
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Denovo Biopharma LLC
12.3.1 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Corporation Information
12.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Products Offered
12.3.5 Denovo Biopharma LLC Recent Development
12.4 Domain Therapeutics SA
12.4.1 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Corporation Information
12.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Products Offered
12.4.5 Domain Therapeutics SA Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Corporation Information
12.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Products Offered
12.5.5 Eli Lilly and Company Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Metabotropic Glutamate Receptor 2 Corporation Information
12.6.2 Johnson & Johnson Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Merck & Co Inc
12.7.1 Merck & Co Inc Metabotropic Glutamate Receptor 2 Corporation Information
12.7.2 Merck & Co Inc Metabotropic Glutamate Receptor 2 Business Overview and Total Revenue
12.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Products Offered
12.7.5 Merck & Co Inc Recent Development
…

13 Metabotropic Glutamate Receptor 2 Manufacturing Cost Analysis
13.1 Metabotropic Glutamate Receptor 2 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2
13.4 Metabotropic Glutamate Receptor 2 Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Metabotropic Glutamate Receptor 2 Distributors List
14.3 Metabotropic Glutamate Receptor 2 Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Metabotropic Glutamate Receptor 2 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2015-2020)
Table 6. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Metabotropic Glutamate Receptor 2 Revenue Share by Region (2015-2020)
Table 8. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Metabotropic Glutamate Receptor 2 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Metabotropic Glutamate Receptor 2 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Metabotropic Glutamate Receptor 2 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Metabotropic Glutamate Receptor 2 Sales Share by Company (2015-2020)
Table 14. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Metabotropic Glutamate Receptor 2 Revenue Share by Company (2015-2020)
Table 16. Global Metabotropic Glutamate Receptor 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2019)
Table 17. Global Metabotropic Glutamate Receptor 2 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Metabotropic Glutamate Receptor 2 Manufacturing Sites and Area Served
Table 19. Manufacturers Metabotropic Glutamate Receptor 2 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Metabotropic Glutamate Receptor 2 Players
Table 22. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Metabotropic Glutamate Receptor 2 Sales Share by Type (2015-2020)
Table 24. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Metabotropic Glutamate Receptor 2 Price (K Pcs) by Type (2015-2020)
Table 26. Global Metabotropic Glutamate Receptor 2 Sales Share by Type (2021-2026)
Table 27. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Metabotropic Glutamate Receptor 2 Revenue Share by Type (2021-2026)
Table 29. Global Metabotropic Glutamate Receptor 2 Price (K Pcs) by Type (2021-2026)
Table 30. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Metabotropic Glutamate Receptor 2 Sales Share by Application (2015-2020)
Table 32. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Metabotropic Glutamate Receptor 2 Price (K Pcs) by Application (2015-2020)
Table 34. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Metabotropic Glutamate Receptor 2 Sales Share by Application (2021-2026)
Table 36. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Metabotropic Glutamate Receptor 2 Revenue Share by Application (2021-2026)
Table 38. Global Metabotropic Glutamate Receptor 2 Price (K Pcs) by Application (2021-2026)
Table 39. United States Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 41. United States Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 43. United States Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
Table 45. Europe Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 47. Europe Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 49. Europe Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 51. China Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 52. China Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 53. China Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 54. China Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 55. China Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 56. China Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
Table 57. Japan Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 59. Japan Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 61. Japan Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
Table 69. India Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Company (2015-2020)
Table 70. India Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2015-2020)
Table 71. India Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2015-2020)
Table 72. India Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2015-2020)
Table 73. India Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2015-2020)
Table 74. India Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2015-2020)
Table 75. Addex Therapeutics Ltd Corporation Information
Table 76. Addex Therapeutics Ltd Description and Business Overview
Table 77. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product
Table 79. Addex Therapeutics Ltd Recent Development
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. Denovo Biopharma LLC Corporation Information
Table 86. Denovo Biopharma LLC Description and Business Overview
Table 87. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product
Table 89. Denovo Biopharma LLC Recent Development
Table 90. Domain Therapeutics SA Corporation Information
Table 91. Domain Therapeutics SA Description and Business Overview
Table 92. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product
Table 94. Domain Therapeutics SA Recent Development
Table 95. Eli Lilly and Company Corporation Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product
Table 99. Eli Lilly and Company Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product
Table 104. Johnson & Johnson Recent Development
Table 105. Merck & Co Inc Corporation Information
Table 106. Merck & Co Inc Description and Business Overview
Table 107. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product
Table 109. Merck & Co Inc Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Metabotropic Glutamate Receptor 2 Distributors List
Table 113. Metabotropic Glutamate Receptor 2 Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 2 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Metabotropic Glutamate Receptor 2 Market Share by Application in 2020 & 2026
Figure 6. Anxiety Disorders Examples
Figure 7. Depression Examples
Figure 8. Schizophrenia Examples
Figure 9. Chronic Pain Examples
Figure 10. Others Examples
Figure 11. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Metabotropic Glutamate Receptor 2 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Metabotropic Glutamate Receptor 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Metabotropic Glutamate Receptor 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Metabotropic Glutamate Receptor 2 Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Metabotropic Glutamate Receptor 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Metabotropic Glutamate Receptor 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Metabotropic Glutamate Receptor 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Metabotropic Glutamate Receptor 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Metabotropic Glutamate Receptor 2 Players Market Share by Revenue in Metabotropic Glutamate Receptor 2 2015 & 2019
Figure 29. Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Metabotropic Glutamate Receptor 2 Revenue Share by Type (2015-2020)
Figure 31. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Metabotropic Glutamate Receptor 2 Revenue Share by Application (2015-2020)
Figure 33. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 35. United States Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 36. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2019
Figure 37. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 38. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2019
Figure 39. China Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2019
Figure 40. China Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 41. China Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2019
Figure 42. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2019
Figure 43. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 44. Japan Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2019
Figure 45. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2019
Figure 46. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 47. Southeast Asia Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2019
Figure 48. India Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2019
Figure 49. India Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2019
Figure 50. India Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2019
Figure 51. Addex Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Denovo Biopharma LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Domain Therapeutics SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck & Co Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Metabotropic Glutamate Receptor 2
Figure 60. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 2
Figure 61. Metabotropic Glutamate Receptor 2 Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

代謝型グルタミン酸受容体4の世界市場レポート2020

Global Metabotropic Glutamate Receptor 4 Sales Market Report 2020
20QY06-07226 2020年6月1日 132Pages
QYResearch社の当調査資料では、代謝型グルタミン酸受容体4のグローバル市場について種類別（VU-0418506、ADX-88178、JBPOS-0101、PXT-2331、その他）、用途別（不安障害、自閉症、うつ病、薬物中毒、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド...

代謝型グルタミン酸受容体1の世界市場レポート2020

Global Metabotropic Glutamate Receptor 1 Sales Market Report 2020
20QY06-07224 2020年6月1日 131Pages
QYResearch社の当調査資料では、代謝型グルタミン酸受容体1のグローバル市場について種類別（FC-311、JBPOS-0101、VU-0467558、その他）、用途別（うつ病、ディジョージ症候群、乳幼児けいれん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査...

代謝型グルタミン酸受容体（MRG）の世界市場 2020年：メーカー別、地域別、種類・用途別

Global Metabotropic Glutamate Receptor (MRG) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
D005-10238 2020年5月28日 109Pages
本調査レポートでは、代謝型グルタミン酸受容体（MRG）の世界市場を広く調査・分析し、今後の市場展望をまとめております。代謝型グルタミン酸受容体（MRG）の種類別市場規模（mGluR2、mGluR4、mGluR5）、用途別市場規模（髄膜炎、敗血症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、...

代謝型グルタミン酸受容体の世界市場 2020年：メーカー別、地域別、種類・用途別

Global Metabotropic Glutamate Receptor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
D005-10239 2020年5月28日 106Pages
本調査レポートでは、代謝型グルタミン酸受容体の世界市場を広く調査・分析し、今後の市場展望をまとめております。代謝型グルタミン酸受容体の種類別市場規模（多糖ワクチン、コンジュゲートワクチン、混合ワクチン、男性Bワクチン）、用途別市場規模（髄膜炎、敗血症、その他）、地域別市場規模（北米、アメリカ、ヨーロ...

インターロイキン2受容体サブユニットアルファの世界市場レポート2020

Global Interleukin 2 Receptor Subunit Alpha Sales Market Report 2020
20QY06-00879 2020年6月2日 130Pages
QYResearch社の当調査資料では、インターロイキン2受容体サブユニットアルファのグローバル市場について種類別（DEL-106、MDNA-209、NKTR-358、APT-602、その他）、用途別（自己免疫疾患、血液がん、卵巣がん、腎細胞がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南...

ペルオキシソーム増殖因子活性化受容体デルタの世界市場レポート2020

Global Peroxisome Proliferator Activated Receptor Delta Sales Market Report 2020
20QY06-03644 2020年6月1日 135Pages
QYResearch社の当調査資料では、ペルオキシソーム増殖因子活性化受容体デルタのグローバル市場について種類別（MTB-2、HPP-593、CNX-013B2、CS-038、MA-0204、その他）、用途別（骨疾患、大腸炎、肥満、骨粗しょう症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南ア...

ムスカリン性アセチルコリン受容体の世界市場レポート2020

Global Muscarinic Acetylcholine Receptor Sales Market Report 2020
20QY06-04046 2020年6月1日 139Pages
QYResearch社の当調査資料では、ムスカリン性アセチルコリン受容体のグローバル市場について種類別（M1、M4、M5、その他）、用途別（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めま...

アデノシン受容体A3の世界市場レポート2020

Global Adenosine Receptor A3 Sales Market Report 2020
20QY06-00651 2020年6月3日 137Pages
QYResearch社の当調査資料では、アデノシン受容体A3のグローバル市場について種類別（HU-010、LJ-1888、CF-602、FM-101、FM-1101、その他）、用途別（毒性学、中枢神経系、皮膚科、固形腫瘍、アトピー性皮膚炎、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、...

線維芽細胞成長因子受容体2の世界市場レポート2020

Global Fibroblast Growth Factor Receptor 2 Sales Market Report 2020
20QY06-07074 2020年6月2日 144Pages
QYResearch社の当調査資料では、線維芽細胞成長因子受容体2のグローバル市場について種類別（ASP-5878、AZD-4547、BAY-1163877、CPL-043、Debio-1347、EDP-317、その他）、用途別（クリニック、病院、その他）、地域別（北米、ヨーロッパ、中国、日本、東南...

オキシステロール受容体LXRベーターの世界市場レポート2020

Global Oxysterols Receptor LXR Beta Sales Market Report 2020
20QY06-01215 2020年6月1日 135Pages
QYResearch社の当調査資料では、オキシステロール受容体LXRベーターのグローバル市場について種類別（AF-122、BMS-779788、SR-9238、VTP-38543、VTP-4、その他）、用途別（クリニック、病院、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区...

代謝型グルタミン酸受容体4の世界市場レポート2020 Market Analysis and Insights: Global Metabotropic Glutamate Receptor 4 Market The global Metabotropic Glutamate Receptor 4 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Metabotropic Glutamate Receptor 4…
代謝型グルタミン酸受容体1の世界市場レポート2020 Market Analysis and Insights: Global Metabotropic Glutamate Receptor 1 Market The global Metabotropic Glutamate Receptor 1 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Metabotropic Glutamate Receptor 1…
代謝型グルタミン酸受容体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Metabotropic Glutamate Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 2 million by 2025, from USD 1 million in 2019. The Metabotropic …
代謝型グルタミン酸受容体（MRG）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Metabotropic Glutamate Receptor (MRG) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metabot…
アデノシン受容体A3の世界市場レポート2020 Market Analysis and Insights: Global Adenosine Receptor A3 Market The global Adenosine Receptor A3 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Adenosine Receptor A3 Scope and Market Size The global Ad…